As of 2024-12-12, the Relative Valuation of Theranexus SA (ALTHX.PA) is (5.86) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.48 EUR, the upside of Theranexus SA based on Relative Valuation is -1328.9%.
The range of the Relative Valuation is (5.85) - (5.65) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 14.1x | 13.8x |
| Forward P/E multiples | 14.6x - 16.4x | 15.5x |
| Fair Price | (5.85) - (5.65) | (5.86) |
| Upside | -1326.8% - -1284.8% | -1328.9% |
| Date | P/E |
| 2024-12-10 | -1.19 |
| 2024-12-09 | -1.17 |
| 2024-12-06 | -1.19 |
| 2024-12-05 | -1.20 |
| 2024-12-04 | -1.20 |
| 2024-12-03 | -1.18 |
| 2024-12-02 | -1.17 |
| 2024-11-29 | -1.24 |
| 2024-11-28 | -1.24 |
| 2024-11-27 | -1.25 |
| 2024-11-26 | -1.25 |
| 2024-11-25 | -1.25 |
| 2024-11-22 | -1.25 |
| 2024-11-21 | -1.26 |
| 2024-11-20 | -1.29 |
| 2024-11-19 | -1.25 |
| 2024-11-18 | -1.25 |
| 2024-11-15 | -1.25 |
| 2024-11-14 | -1.26 |
| 2024-11-13 | -1.26 |
| 2024-11-12 | -1.27 |
| 2024-11-11 | -1.24 |
| 2024-11-08 | -1.27 |
| 2024-11-07 | -1.26 |
| 2024-11-06 | -1.25 |
| 2024-11-05 | -1.27 |
| 2024-11-04 | -1.27 |
| 2024-11-01 | -1.30 |
| 2024-10-31 | -1.31 |
| 2024-10-30 | -1.28 |
| 2024-10-29 | -1.32 |
| 2024-10-28 | -1.32 |
| 2024-10-25 | -1.36 |
| 2024-10-24 | -1.41 |
| 2024-10-23 | -1.52 |
| 2024-10-22 | -1.54 |
| 2024-10-21 | -1.55 |
| 2024-10-18 | -1.25 |
| 2024-10-17 | -1.24 |
| 2024-10-16 | -1.27 |
| 2024-10-15 | -1.27 |
| 2024-10-14 | -1.28 |
| 2024-10-11 | -1.29 |
| 2024-10-10 | -1.30 |
| 2024-10-09 | -1.29 |
| 2024-10-08 | -1.24 |
| 2024-10-07 | -1.30 |
| 2024-10-04 | -1.34 |
| 2024-10-03 | -1.32 |
| 2024-10-02 | -1.36 |